# GAP-Net Site Optimization Conference 2022: Event Review This year’s GAP Foundation conference was a collaborative event with many interesting discussions on issues related to research in Alzheimer’s Disease. 8 Mar 22 blog # GAP-Net Site Optimization Conference 2022: Event Review [ ](https://x.com/intent/tweet?url=https://ixico.com/news-and-resources/blog/gap-net-site-optimization-conference-2022-event-review/) [ ](https://bsky.app/intent/compose?text=https://ixico.com/news-and-resources/blog/gap-net-site-optimization-conference-2022-event-review/) [ ](https://www.facebook.com/sharer/sharer.php?u=https://ixico.com/news-and-resources/blog/gap-net-site-optimization-conference-2022-event-review/) [ ](https://www.linkedin.com/shareArticle?mini=true&url=https://ixico.com/news-and-resources/blog/gap-net-site-optimization-conference-2022-event-review/) The [Global Alzheimer's Platform Foundation](https://globalalzplatform.org/)’s GAP-Net Site Optimization Conference 2022 gave all participants an update on the important [Bio-Hermes trial](https://ixico.com/news-and-resources/blog/ixico-and-gap-foundation-alzheimers-and-the-bio-hermes-study/) which is going very well. This year’s conference was a highly collaborative event with many interesting presentations and discussions on issues related to research in Alzheimer’s Disease. One prominent topic was ensuring we work together as an industry to increase the diversity of populations within clinical trials. This ensures biomarkers and treatment effects are thoroughly and effectively researched for a range of previously under-represented patient populations. GAP-NET sites are at the forefront of prioritizing diversity. Other topics discussed within the presentations, round tables and panels included access to imaging ligands, supply of rater specialists, site start-up, use of MRI, blood and computerized cognitive assessments as biomarkers to ensure correct patient recruitment, and many more. IXICO also showcased [IXIQ.Ai](https://ixico.com/news-and-resources/blog/), our latest brain segmentation technology in a presentation by Chief Scientific Officer [Robin Wolz](https://ixico.com/about-us/leadership-team/). Robin spoke about the development and function of IXIQ.Ai, demonstrating to sponsors how IXIQ.Ai can support patient selection in AD trials and how sponsors could achieve greater imaging sensitivity to smaller treatment effects with this novel AI platform. Overall, the GAP-Net Site Optimization Conference was an informative event and an excellent opportunity to make contact with our colleagues who are contributing in different and important ways to [Alzheimer’s disease](https://ixico.com/about-us/therapeutic-areas/alzheimers-disease/) research. [ Back to Blog ](/news-and-resources/blog/) ### Recents ![Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/assets/blog-images/Alzheimers-biomarkers__ScaleMaxWidthWzgwMF0_FillMaxWzgwMCw0NTBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp) 29 Sep 26 blog [Beyond Diagnosis: 8 MRI and PET Biomarkers Shaping Alzheimer's Clinical Trials](/news-and-resources/blog/pet-mri-biomarkers-alzheimers-clinical-trials/) [White matter hyperintensities: A precision neurology tool for Alzheimer’s patient stratification and improved trial sensitivity? ](/news-and-resources/blog/white-matter-hyperintensities-a-precision-neurology-tool-for-alzheimers-patient-stratification-and-improved-trial-sensitivity/) [Neuromelanin MRI: An Early, Longitudinal Biomarker for Parkinson’s Disease](/news-and-resources/blog/neuromelanin-mri-an-early-longitudinal-biomarker-for-parkinsons-disease/) [From Information to Intelligence: New Platform Identity Explained](/news-and-resources/blog/from-information-to-intelligence-bram-goodren-ceo-of-ixico-explains-the-new-identity-of-the-ixi-platform-and-why-it-matters/) [Advancing HD Clinical Trials with Automated Imaging: What the Latest Research Shows](/news-and-resources/blog/advancing-hd-clinical-trials-with-automated-imaging-what-the-latest-research-shows/) ### Library [November 2026](/news-and-resources/blog/archive/2026/11/) [October 2026](/news-and-resources/blog/archive/2026/10/) [September 2026](/news-and-resources/blog/archive/2026/09/) [July 2026](/news-and-resources/blog/archive/2026/07/) [June 2026](/news-and-resources/blog/archive/2026/06/) [May 2026](/news-and-resources/blog/archive/2026/05/) [April 2026](/news-and-resources/blog/archive/2026/04/) [March 2026](/news-and-resources/blog/archive/2026/03/) [February 2026](/news-and-resources/blog/archive/2026/02/) [January 2026](/news-and-resources/blog/archive/2026/01/) [2025](/news-and-resources/blog/archive/2025/) [2024](/news-and-resources/blog/archive/2024/) [2023](/news-and-resources/blog/archive/2023/) [2022](/news-and-resources/blog/archive/2022/) [2021](/news-and-resources/blog/archive/2021/) [2020](/news-and-resources/blog/archive/2020/) [2019](/news-and-resources/blog/archive/2019/)